Forrest et al. [77], reported that downregulation of SACM1L can disrupt axonal transport in a fly model of Amyotrophic Lateral Sclerosis (ALS) and in humans who have ALS, implicating a crucial role of phosphoinositide levels in ALS etiology. Here, SACM1L is linked to amyotrophic lateral sclerosis.